
CogState Ltd
ASX:CGS

Net Margin
CogState Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
AU |
![]() |
CogState Ltd
ASX:CGS
|
314.1m AUD |
16%
|
|
US |
![]() |
Veeva Systems Inc
NYSE:VEEV
|
47.2B USD |
27%
|
|
US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
10%
|
|
AU |
![]() |
Pro Medicus Ltd
ASX:PME
|
33.5B AUD |
52%
|
|
US |
![]() |
Doximity Inc
NYSE:DOCS
|
11.5B USD |
39%
|
|
JP |
![]() |
M3 Inc
TSE:2413
|
1.3T JPY |
14%
|
|
SE |
![]() |
Sectra AB
STO:SECT B
|
71.4B SEK |
27%
|
|
US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
6.2B USD |
3%
|
|
US |
![]() |
Inspire Medical Systems Inc
NYSE:INSP
|
3.8B USD |
8%
|
|
CN |
![]() |
Winning Health Technology Group Co Ltd
SZSE:300253
|
23.4B CNY |
3%
|
|
IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
267.1B INR | N/A |
CogState Ltd
Glance View
Cogstate Ltd. is a global cognitive science company. The firm provides computerized cognitive tests across various domains and support electronic clinical outcome assessment (eCOA) solutions. The firm's segment includes Clinical trials, Healthcare and Research. In the Clinical trials segment, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. Research segment offers various research studies and academic collaborations across various indication of diseases.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on CogState Ltd's most recent financial statements, the company has Net Margin of 15.6%.